Inogen makes three appointments to exec team

BEVERLY, Mass. – Inogen has made three appointments to its executive team in a move the company says will accelerate its next phase of growth. The company has named:

• Jason Richardson as CFO, succeeding Michael Bourque, effective April 6;
• Dominic Hulton as chief marketing officer, effective April 1; and
• Corey Moritz as vice president, U.S. business-to-business sales, who joined on March 9.

Jason Richardson

Richardson joins Inogen from Baxter International Inc., where he most recently served as CFO and vice president of the Healthcare Systems & Technologies segment, a $3 billion publicly reported business. In this role, he was a central figure in Baxter’s integration of Hillrom, driving growth initiatives and improved operating performance. Prior to Baxter’s acquisition of Hillrom, Richardson held a variety of senior finance leadership roles at Hillrom, including overseeing its Respiratory Care franchise, a durable medical equipment (DME) business focused on cystic fibrosis, bronchiectasis, and other respiratory diseases.

“We are pleased to welcome Jason as Inogen’s next chief financial officer,” said Kevin Smith, president and CEO Inogen. “Jason’s deep expertise in finance and operations across the medical device and healthcare industries will be instrumental as we focus on delivering superior respiratory solutions to patients around the world and driving sustainable growth.”

Dominic Hulton

Hulton is a globally experienced commercial leader with more than 20 years of experience driving growth, expanding markets and leading organizational transformation in medical technology. He spent the last 11 years at Insulet Corp., where he served as vice president of international marketing and sales excellence. In that role, he led global product launches, built cross-functional teams and scaled commercial operations.

Corey Moritz

Moritz is a health care executive with more than two decades of experience driving commercial transformation, revenue growth and scalable expansion across medical devices, respiratory care and health services organizations. He has successfully built six sales forces while delivering sustained growth, margin expansion and strong commercial infrastructure. He previously served as chief commercial officer of Rhythm Healthcare, where he had a strong track record of driving significant revenue growth across multiple years.